Pharmacological Activation of Nrf2 Enhances Functional Liver Regeneration
Benjamin Chan, Mohamed Elmasry, Shiva S. Forootan, Giusy Russomanno et autres
gb (code pays fourni par la source)
54 citations
Hepatology
Neil R. Kitteringham
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
123Publications signalées
10540Citations signalées
3Affiliations récentes
Les institutions déclarées
Les domaines associés
Genomics, phytochemicals, and oxidative stressPharmacogenetics and Drug MetabolismGlutathione Transferases and PolymorphismsDrug-Induced Hepatotoxicity and ProtectionLiver physiology and pathology
Les publications récentes
Assessing technical and biological variation in SWATH-MS-based proteomic analysis of chronic lymphocytic leukaemia cells
Gina Eagle, John Herbert, Jianguo Zhuang, Melanie Oates et autres
gb (code pays fourni par la source)
9 citations
Scientific Reports
Exosomal Transport of Hepatocyte‐Derived Drug‐Modified Proteins to the Immune System
Monday O. Ogese, Rosalind E. Jenkins, Kareena Adair, Arun Tailor et autres
gb (code pays fourni par la source)
45 citations
Hepatology
Development of an orthotopic syngeneic murine model of colorectal cancer for use in translational research
Jonathan Evans, Bolesław Winiarski, Paul Sutton, Lorenzo Ressel et autres
gb (code pays fourni par la source)
13 citations
Laboratory Animals
Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan Evans, Bolesław Winiarski, Paul Sutton, Robert Jones et autres
gb, hk (code pays fourni par la source)
6 citations
Oncotarget
Human OATP1B1 (SLCO1B1) transports sulfated bile acids and bile salts with particular efficiency
Beáta Tóth, Márton Jani, Erzsébet Beéry, Teresa Heslop et autres
hu, gb, fr (code pays fourni par la source)
13 citations
Toxicology in Vitro
The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
Jonathan Evans, Bolesław Winiarski, Paul Sutton, Robert Jones et autres
gb, hk (code pays fourni par la source)
62 citations
Oncotarget
Linking genotype to clinical phenotype through proteomic analysis of CLL trial samples
Gina Eagle, Jianguo Zhuang, Melanie Oates, Neil R. Kitteringham et autres
0 citations
Leukemia & lymphoma/Leukemia and lymphoma
Dynamic and accurate assessment of acetaminophen-induced hepatotoxicity by integrated photoacoustic imaging and mechanistic biomarkers in vivo
Nathalie Brillant, Mohamed Elmasry, Josep M. Monné Rodríguez, Jack Sharkey et autres
gb, de, ch (code pays fourni par la source)
25 citations
Toxicology and Applied Pharmacology
Donor-Dependent and Other Nondefined Factors have Greater Influence on the Hepatic Phenotype than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells
James A. Heslop, Richard Kia, Christopher S. Pridgeon, Rowena Sison‐Young et autres
5 citations
Stem Cells Translational Medicine
Donor-Dependent and Other Nondefined Factors Have Greater Influence on the Hepatic Phenotype Than the Starting Cell Type in Induced Pluripotent Stem Cell Derived Hepatocyte-Like Cells
James A. Heslop, Richard Kia, Christopher S. Pridgeon, Rowena Sison‐Young et autres
gb (code pays fourni par la source)
19 citations
Stem Cells Translational Medicine
The impact of P450 oxidoreductase knock out on systemic exposure to rosuvastatin, atorvastatin and atorvastatin metabolites
Richard M. Turner, Mark Bayliss, Daniel F. Carr, Neil R. Kitteringham et autres
0 citations
BNTIC News n’est pas le producteur de ces données. Les publications sont interrogées à la demande dans Crossref, OpenAIRE, DOAJ, Europe PMC, HAL, DataCite, AfricArXiv, ROR et la Banque mondiale, sans clé d’accès. OpenAlex reste optionnel. Aucun service payant n’est nécessaire et aucune donnée externe n’est enregistrée en base. Consulter les sources et leurs limites.